Suxiang Chen (also known as John Chen) is a Honorary Research Fellow at Personalised Medicine Centre (PMC), Health Futures Institute, Murdoch University, Australia.
John received his Bachelor degree of Agriculture in 2010 in South China Agricultural University (SCAU). He then obtained his Master degree in Biotechnology (Advanced) and a second Master degree in Technology and Innovation Management from the University of Queensland (UQ) in 2013 and 2014 respectively. Later, he worked in Darui Biotechnology Co. Ltd and Gene Denovo Biotechnology Co. Ltd in Guangzhou, China as a core technician and technical support team member respectively. He received his PhD degree at Murdoch University under the supervision of Assoc. Prof. Rakesh N. Veedu, Prof. Steve Wilton, and Prof. Sue Fletcher in 2021. He also worked in the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT), Murdoch University as laboratory assistant (2016-2019) and research assistant (2019-2020) during his PhD journey, respectively. He worked in CMMIT as a postdoctoral scientist from 2022 to 2025.
His research focus is on antisense oligonucleotides (ASOs), especially development and optimization of ASOs as research tools, therapeutics for human maladies, and pesticides for plant protection.
Suxiang Chen (also known as John Chen) is a Honorary Research Fellow at Personalised Medicine Centre (PMC), Health Futures Institute, Murdoch University, Australia.
John received his Bachelor degree of Agriculture in 2010 in South China Agricultural University (SCAU). He then obtained his Master degree in Biotechnology (Advanced) and a second Master degree in Technology and Innovation Management from the University of Queensland (UQ) in 2013 and 2014 respectively. Later, he worked in Darui Biotechnology Co. Ltd and Gene Denovo Biotechnology Co. Ltd in Guangzhou, China as a core technician and technical support team member respectively. He received his PhD degree at Murdoch University under the supervision of Assoc. Prof. Rakesh N. Veedu, Prof. Steve Wilton, and Prof. Sue Fletcher in 2021. He also worked in the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT), Murdoch University as laboratory assistant (2016-2019) and research assistant (2019-2020) during his PhD journey, respectively. He worked in CMMIT as a postdoctoral scientist from 2022 to 2025.
His research focus is on antisense oligonucleotides (ASOs), especially development and optimization of ASOs as research tools, therapeutics for human maladies, and pesticides for plant protection.